Comparable Long-Term Efficacy of Lopinavir/Ritonavir and Similar Drug-Resistance Profiles in Different HIV-1 Subtypes

BACKGROUND: Analysis of potentially different impact of Lopinavir/Ritonavir (LPV/r) on non-B subtypes is confounded by dissimilarities in the conditions existing in different countries. We retrospectively compared its impact on populations infected with subtypes B and C in Israel, where patients inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossman, Zehava, Schapiro, Jonathan M., Levy, Itzchak, Elbirt, Daniel, Chowers, Michal, Riesenberg, Klaris, Olstein-Pops, Karen, Shahar, Eduardo, Istomin, Valery, Asher, Ilan, Gottessman, Bat-Sheva, Shemer, Yonat, Elinav, Hila, Hassoun, Gamal, Rosenberg, Shira, Averbuch, Diana, Machleb-Guri, Keren, Kra-Oz, Zipi, Radian-Sade, Sara, Rudich, Hagit, Ram, Daniela, Maayan, Shlomo, Agmon-Levin, Nancy, Sthoeger, Zev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903498/
https://www.ncbi.nlm.nih.gov/pubmed/24475093
http://dx.doi.org/10.1371/journal.pone.0086239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903498/
https://www.ncbi.nlm.nih.gov/pubmed/24475093
http://dx.doi.org/10.1371/journal.pone.0086239

Ejemplares similares